the recent FDA release of Andexxa, the new Factor Xa inhibitor antidote. The second link also provides a larger scientific and biochemical pathway for clotting. It is also from Nature magazine, showing the central place of Factor Xa and new drug development areas. The "approval" has been a long time coming. This was "fast-tracked" 2 years ago. It has been promised in late 2017, early 2018, and now -2019.
For more information, contact us at 859-721-1414 or myhealth@prevmedheartrisk.com. Also, check out the following resources: